Obesity drugs improve heart health: Study shows additional benefits of semaglutide and tirzepatide Dr. Kamal Kant Kohli13 Nov 2025 8:15 PM ISTInjectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical...
Gliclazide - Revisiting a Preferred Sulphonylurea in 2025 - Dr Silima Tarenia and Dr Shehzad Ruman Deeksha Bhandari13 Nov 2025 6:00 PM ISTOn this World Diabetes Day, we bring you a special episode of Dia Dialogues titled "Gliclazide - Revisiting a Preferred Sulphonylurea in 2025." ...
Heart Drug Verapamil May Cut Risk of Type 2 Diabetes, New Research Suggests Medha Baranwal13 Nov 2025 9:15 AM ISTAustralia: A new study published in Diabetes Care has found that verapamil, a calcium channel blocker (CCB) commonly used for hypertension and heart...
Medical Bulletin 12/November/2025 Dr. Bhumika Maikhuri12 Nov 2025 4:00 PM ISTHere are the top medical news for the day:Targeted Vitamin D Therapy Cuts Risk of Repeat Heart Attack by Half: Study Finds A new study has reported...
Incretin-Based Diabetes Drugs Show No Added Risk of Pancreatitis but Slight Increase in Biliary Events, Study Finds Medha Baranwal12 Nov 2025 12:15 PM ISTUSA: A new large-scale analysis published in Diabetes Care has provided important insights into the safety of incretin-based therapies in patients...
Semaglutide and Tirzepatide Cut Heart Risks in Type 2 Diabetes: Study Finds Dr. Bhumika Maikhuri12 Nov 2025 8:30 AM ISTA new database study has found that the injectable weight-loss drugs semaglutide and tirzepatide significantly reduce the risk of serious ...
Planetary Health Diet tied to Lower Heart Attack Risk and Better Weight Control in Women with Gestational Diabetes: JAMA Dr. Shravani Dali11 Nov 2025 8:15 AM ISTA cohort study published in *JAMA Network Open* has revealed that women with a history of gestational diabetes who adhered more closely to the...
Mazdutide Shows Superior Efficacy Over Semaglutide in Type 2 Diabetes with Obesity: Study Dr. Kamal Kant Kohli5 Nov 2025 8:30 PM ISTResearchers have found in a new DREAMS-3 trial, that GLP-1/GCG dual receptor agonist mazdutide outperformed semaglutide in reducing HbA1c levels and...
Heatwaves linked to rise in sleep apnoea case, reveals research Dr. Kamal Kant Kohli5 Nov 2025 8:30 PM ISTDuring heatwaves, there is an increase in the number of people suffering with obstructive sleep apnoea (OSA), according to a major study...
A Hidden Epidemic: Addressing Visceral Fat and Insulin Resistance in Non-Obese T2DM with Pioglitazone-Based Therapies Dr. K M Suryanarayana VSM5 Nov 2025 11:15 AM ISTMetabolically unhealthy non-obese individuals (MUNO) comprise around 20% of the normal-weight population and have a 3.14-fold higher risk of...
Osteoarthritis Signals Higher Risk of Cardiovascular-Kidney-Metabolic Multimorbidity Dr Riya Dave4 Nov 2025 8:15 PM ISTResearchers discovered that osteoarthritis (OA), previously thought to be a degenerative joint disease, is highly linked to the development and...
Obesity Discussions to Take Spotlight at RSSDI 2025; Experts to Delve into Tirzepatide's Dual Agonism in Metabolic Care Deeksha Bhandari4 Nov 2025 12:20 PM ISTThe topic of obesity and metabolic disease will take centre stage at the upcoming 53rd Annual Conference of the Research Society for the Study of...
